Suchergebnisse - "Sehgal, Kartik"

PubPharm (39)

1

Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin : cohort study

enthalten in: BMJ (Clinical research ed.) | 2024

von Gupta, S. | Glezerman, I. | Hirsch, J. | +23

2

Multifocal, Asymmetric Bilateral Primary Aldosteronism Cannot be Excluded by Strong Adrenal Vein Sampling Lateralization : An International Retrospective Cohort Study

enthalten in: Hypertension (Dallas, Tex. : 1979) | 2024

von Turcu, A. | Tezuka, Y. | Lim, J. | +18

3

Successful rechallenge with pembrolizumab after case of progressive immunotherapy-related mucocutaneous eruption (PIRME), a Stevens-Johnson syndrome-like reaction

enthalten in: International journal of dermatology | 2023

von Shi, C. | Shaughnessy, M. | Sehgal, K. | +4

4

Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Bikas, A. | Ahmadi, S. | Pappa, T. | +10

5

Association of Pretreatment Circulating Tumor Tissue-Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer

enthalten in: JAMA otolaryngology-- head & neck surgery | 2022

von Rettig, E. | Wang, A. | Tran, N. | +14

CommentIn: JAMA Otolaryngol Head Neck Surg. 2022 Dec 1;148(12):1130-1131. - PMID 36301555

6

Association of extended dosing intervals or delays in pembrolizumab-based regimens with survival outcomes in advanced non-small cell lung cancer

enthalten in: bioRxiv.org | 2022

von Sehgal, K. | Bulumulle, A. | Brody, H. | +12

7

Progressive Multifocal Leukoencephalopathy After Chimeric Antigen Receptor T-Cell Therapy for Recurrent Non-Hodgkin Lymphoma

enthalten in: Journal of hematology | 2021

von Ahrendsen, J. | Sehgal, K. | Sarangi, S. | +4

8

Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer

enthalten in: Clinical lung cancer | 2021

von Sehgal, K. | Bulumulle, A. | Brody, H. | +12

9

Post-acute COVID-19 syndrome

enthalten in: Nature medicine | 2021

von Nalbandian, A. | Sehgal, K. | Gupta, A. | +31

CommentIn: Recenti Prog Med. 2021 May;112(5):335-337. - PMID 34003184

10

Clinical Benefit of Tyrosine Kinase Inhibitors in Advanced Lung Cancer with EGFR-G719A and Other Uncommon EGFR Mutations

enthalten in: The oncologist | 2021

von Sehgal, K. | Rangachari, D. | VanderLaan, P. | +2